News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,937 Results
Type
Article (14291)
Company Profile (105)
Press Release (260533)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88538)
Career Advice (465)
Deals (15457)
Drug Delivery (73)
Drug Development (36739)
Employer Resources (50)
FDA (6410)
Job Trends (6238)
News (151076)
Policy (14142)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (447)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23382)
ALS (57)
Alzheimer's disease (497)
Antibody-drug conjugate (ADC) (99)
Approvals (6603)
Artificial intelligence (205)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4375)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1317)
Cardiovascular disease (151)
Career advice (418)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32031)
Collaboration (730)
Compensation (326)
Complete response letters (33)
COVID-19 (778)
CRISPR (43)
C-suite (438)
Cystic fibrosis (58)
Data (1827)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1385)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (114)
Drug pricing (115)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33587)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39180)
Executive appointments (531)
FDA (7521)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (436)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (439)
Government (1405)
Grass and pollen (4)
Guidances (164)
Healthcare (3593)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (842)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5946)
IRA (33)
Job creations (2056)
Job search strategy (374)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3450)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1532)
Medtech (1539)
Mergers & acquisitions (9943)
Metabolic disorders (434)
Multiple sclerosis (50)
NASH (14)
Neurodegenerative disease (84)
Neuropsychiatric disorders (37)
Neuroscience (916)
Neurotech (1)
NextGen: Class of 2026 (1595)
Non-profit (610)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (110)
Pancreatic cancer (51)
Parkinson's disease (83)
Partnered (11)
Patents (221)
Patient recruitment (117)
Peanut (12)
People (29834)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8310)
Phase 2 (13523)
Phase 3 (12211)
Pipeline (1912)
Policy (135)
Postmarket research (1401)
Preclinical (3344)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (350)
Real estate (2664)
Recruiting (18)
Regulatory (10976)
Reports (15)
Research institute (578)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (82)
Series B (51)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1648)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Last 7 days (178)
Last 30 days (682)
Last 365 days (10482)
2026 (957)
2025 (10797)
2024 (12608)
2023 (14350)
2022 (19659)
2021 (20179)
2020 (19127)
2019 (14942)
2018 (11761)
2017 (13945)
2016 (13187)
2015 (15512)
2014 (12455)
2013 (10614)
2012 (11425)
2011 (11960)
2010 (10904)
Location
Africa (319)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20910)
Australia (2708)
California (3192)
Canada (1482)
China (550)
Colorado (145)
Connecticut (129)
Delaware (123)
Europe (40950)
Florida (602)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (350)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (424)
Massachusetts (2609)
Michigan (76)
Minnesota (168)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1396)
New Mexico (7)
New York (915)
North Carolina (619)
North Dakota (2)
Northern California (1455)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (734)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1390)
Tennessee (53)
Texas (459)
United States (12779)
Utah (59)
Virginia (161)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,937 Results for "neurotech pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
September 3, 2025
·
1 min read
Insights
The New Gold Rush in Brain Science
Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks.
BioSpace
spoke to investors at JPM26 to get their take on recent bets in new therapies and neurotech.
January 22, 2026
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Neurotech Granted Permanent J-Code (J3403) for ENCELTO™ (revakinagene taroretcel-lwey), Effective October 1, 2025
September 30, 2025
·
7 min read
Press Releases
Neurotech Appoints Beth Marsh as Chief Commercial Officer
April 21, 2025
·
8 min read
Press Releases
Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel)
March 6, 2025
·
6 min read
Press Releases
Neurotech is Changing the Way We Treat Disease and Understand the Brain; Are Our Medical and Legal Institutions Ready?
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks
October 4, 2024
·
1 min read
Business
Alex Gorsky Joins Neurotech’s Board as Lead Director
Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.
September 13, 2023
·
3 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
Press Releases
Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R
May 14, 2025
·
4 min read
Press Releases
Phantom Neuro Receives FDA Breakthrough Device and TAP Designations, Solidifying Position as a Neurotech Leader
March 6, 2025
·
3 min read
1 of 27,494
Next
